CD38 deficiency suppresses the initiation and progression of NAFLD by reducing lipid accumulation and suppressing oxidative stress via the activation of sirtuins such as Sirt1 and Sirt3 [97] (Figure 4a). This evidence concerns the gene CD38 and metabolic dysfunction-associated steatotic liver disease.